Sohini Das And Arnab Dutta

Stories by Sohini Das And Arnab Dutta

Lockdown curbs may scorch summer sales

Lockdown curbs may scorch summer sales

Rediff.com   24 Apr 2020

With states in north India imposing stricter measures to curb intra-state movement after April 20, makers of summer products such as air conditioners, refrigerators, colas, and ice creams are estimating a 25-60 per cent drop in yearly sales.

Covid-19: Mumbai to ramp up testing to 4,000 a day

Covid-19: Mumbai to ramp up testing to 4,000 a day

Rediff.com   21 Apr 2020

Mumbai, with an estimated population of nearly 20 million, has been testing 1,200-1,400 people per day. Delay in the delivery of rapid antibody test kits has forced the BMC to restrict its testing net.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com   21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Big drugmakers step in to develop, import test kits

Big drugmakers step in to develop, import test kits

Rediff.com   20 Apr 2020

Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.

Lockdown puts question mark over corporate results

Lockdown puts question mark over corporate results

Rediff.com   20 Apr 2020

Most listed corporate entities in the country are in a fix. With the sudden declaration in late March of a nationwide lockdown to tackle the Covid-19 pandemic, the final calculations of their financial results for the year 2019-20 (FY20) are hanging in limbo. Till April 19, only 41 of the 3,947 companies listed on the BSE have managed to finalise the dates for the declaration of their yearly financial results.

Stool sampling among Covid-19 test options before govt

Stool sampling among Covid-19 test options before govt

Rediff.com   18 Apr 2020

Private diagnostic laboratories have already approached the respective state governments and the municipalities where they are operating to approve protocols for such testing in clusters, reports Sohini Das.

India Inc hails reboot bid, buckles up to deliver

India Inc hails reboot bid, buckles up to deliver

Rediff.com   16 Apr 2020

While FMCG companies were not barred from carrying out their operations during the 21-day lockdown, since most manufacture staples and essential products, capacity utilisation remained poor, owing to the restricted movement of raw materials, finished goods, and labour.

As OPD footfalls drop, private hospitals battle for survival

As OPD footfalls drop, private hospitals battle for survival

Rediff.com   11 Apr 2020

Private hospitals, especially smaller standalone ones, are staring at a crisis that they were not prepared for. Analysts say larger corporate chains have to brace up for at least six months for business to return to normal.

FMCG cos see huge demand but hampered by low capacity utilisation

FMCG cos see huge demand but hampered by low capacity utilisation

Rediff.com   11 Apr 2020

Top companies reported that despite most of them making staples and essential products, movement of raw material, goods and labour remained restricted, impacting sales.

Manufacturing cos look to kickstart ops post-lockdown

Manufacturing cos look to kickstart ops post-lockdown

Rediff.com   8 Apr 2020

According to sources, government officials have asked industry bodies and manufacturers to submit key concerns and requirements to begin manufacturing activity.

Corona effect: Job offers for IIMs, IITians cancelled

Corona effect: Job offers for IIMs, IITians cancelled

Rediff.com   7 Apr 2020

What will happen to the job placement and summer internship plans of India's management and IIT students? Many campuses are stepping in to help students hang on to their placements, in spite of the lockdown.

India lifts curbs on exports of 13 active pharma ingredients

India lifts curbs on exports of 13 active pharma ingredients

Rediff.com   7 Apr 2020

A leading exporter said, there is enough stock of paracetamol in the country. At present, the US, which has become the epicentre of the COVID-19 outbreak, needs paracetamol. He further said India would lose its credibility as the "pharmacy of the world" if it adopts protectionist policies during such a crisis.

Private insurers want standard rates for treatment

Private insurers want standard rates for treatment

Rediff.com   6 Apr 2020

Cost of the diagnostic test for Covid-19 has been fixed at Rs 4,500 per test by the government. Hospitals, however, do not think this is feasible.

ICMR wants rapid tests in India's coronavirus hotspots

ICMR wants rapid tests in India's coronavirus hotspots

Rediff.com   6 Apr 2020

The ICMR has already approved a bunch of rapid test kits for launch. The health ministry admitted that clusters of COVID-19 had appeared in many states and the risk of further spread remains very high.

States rope in pvt hospitals to fight coronavirus

States rope in pvt hospitals to fight coronavirus

Rediff.com   4 Apr 2020

In the past one week alone, Rajasthan, Madhya Pradesh, Chhattisgarh, and Andhra Pradesh have issued orders to take over private hospitals in some districts. Sohini Das, Vinay Umarji and Gireesh Babu report.

India Inc lines up as demand for rapid testing for coronavirus grows

India Inc lines up as demand for rapid testing for coronavirus grows

Rediff.com   3 Apr 2020

The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.

Smartphone market may remain flat in 2020

Smartphone market may remain flat in 2020

Rediff.com   2 Apr 2020

Even as most manufacturers are still assessing the overall impact on their businesses, early projections suggest the market may grow at its lowest ever rate, in 2020.

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com   1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

Traders seek Army's help to distribute medicines

Traders seek Army's help to distribute medicines

Rediff.com   31 Mar 2020

The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com   28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.